News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
153,107 Results
Type
Article (12109)
Company Profile (53)
Press Release (140945)
Multimedia
Podcasts (7)
Webinars (3)
Section
Business (42702)
Career Advice (122)
Deals (7515)
Drug Delivery (11)
Drug Development (20460)
Employer Resources (14)
FDA (3519)
Job Trends (2921)
News (74011)
Policy (6683)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
Academia (784)
Accelerated approval (10)
Adcomms (5)
Allergies (23)
Alliances (14677)
ALS (48)
Alzheimer's disease (450)
Antibody-drug conjugate (ADC) (83)
Approvals (3668)
Artificial intelligence (100)
Autoimmune disease (29)
Automation (6)
Bankruptcy (26)
Best Places to Work (2582)
BIOSECURE Act (3)
Biosimilars (68)
Biotechnology (49)
Bladder cancer (41)
Brain cancer (24)
Breast cancer (113)
Cancer (1148)
Cardiovascular disease (104)
Career advice (108)
Career pathing (2)
CAR-T (73)
CDC (1)
Celiac Disease (1)
Cell therapy (235)
Cervical cancer (3)
Clinical research (17187)
Collaboration (563)
Compensation (207)
Complete response letters (18)
COVID-19 (796)
CRISPR (55)
C-suite (211)
Cystic fibrosis (95)
Data (1760)
Denatured (1)
Depression (23)
Diabetes (81)
Diagnostics (2157)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (80)
Drug pricing (6)
Duchenne muscular dystrophy (124)
Earnings (14794)
Editorial (8)
Employer branding (3)
Employer resources (13)
Events (19870)
Executive appointments (194)
FDA (4375)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (11)
Funding (333)
Gene editing (135)
Generative AI (5)
Gene therapy (344)
GLP-1 (158)
Government (791)
Grass and pollen (1)
Guidances (89)
Healthcare (3366)
HIV (12)
Huntington's disease (23)
IgA nephropathy (32)
Immunology and inflammation (30)
Immuno-oncology (7)
Indications (29)
Infectious disease (842)
Inflammatory bowel disease (55)
Inflation Reduction Act (2)
Influenza (18)
Intellectual property (54)
Interviews (14)
IPO (3179)
IRA (2)
Job creations (514)
Job search strategy (104)
JPM (9)
Kidney cancer (1)
Labor market (3)
Layoffs (70)
Legal (1327)
Liver cancer (28)
Longevity (2)
Lung cancer (171)
Lymphoma (121)
Machine learning (7)
Management (1)
Manufacturing (186)
MASH (19)
Medical device (1478)
Medtech (1485)
Mergers & acquisitions (4618)
Metabolic disorders (219)
Multiple sclerosis (27)
NASH (2)
Neurodegenerative disease (90)
Neuropsychiatric disorders (14)
Neuroscience (791)
NextGen: Class of 2026 (953)
Non-profit (752)
Now hiring (6)
Obesity (105)
Opinion (56)
Ovarian cancer (34)
Pain (24)
Pancreatic cancer (41)
Parkinson's disease (94)
Partnered (5)
Patents (95)
Patient recruitment (109)
Peanut (2)
People (12561)
Pharmaceutical (5)
Pharmacy benefit managers (4)
Phase 1 (5750)
Phase 2 (7634)
Phase 3 (5957)
Pipeline (1373)
Policy (21)
Postmarket research (463)
Preclinical (2378)
Press Release (20)
Prostate cancer (49)
Psychedelics (3)
Radiopharmaceuticals (41)
Rare diseases (470)
Real estate (1101)
Recruiting (3)
Regulatory (5743)
Reports (15)
Research institute (907)
Resumes & cover letters (11)
Rett syndrome (26)
RNA editing (12)
RSV (9)
Schizophrenia (28)
Series A (58)
Series B (53)
Service/supplier (2)
Sickle cell disease (48)
Special edition (3)
Spinal muscular atrophy (141)
Sponsored (8)
Startups (1019)
Stomach cancer (1)
Supply chain (17)
Tariffs (3)
The Weekly (6)
Vaccines (175)
Venture capital (16)
Weight loss (36)
Women's health (13)
Date
Today (8)
Last 7 days (136)
Last 30 days (500)
Last 365 days (7190)
2026 (742)
2025 (7222)
2024 (8600)
2023 (9544)
2022 (14382)
2021 (14294)
2020 (12443)
2019 (9198)
2018 (6971)
2017 (7655)
2016 (6877)
2015 (8342)
2014 (6129)
2013 (5064)
2012 (4999)
2011 (5080)
2010 (4581)
Location
Africa (186)
Alabama (8)
Alaska (2)
Arizona (27)
Arkansas (1)
Asia (24720)
Australia (3069)
California (2356)
Canada (680)
China (437)
Colorado (72)
Connecticut (77)
Delaware (30)
Europe (25365)
Florida (275)
Georgia (33)
Hawaii (1)
Idaho (4)
Illinois (89)
India (36)
Indiana (174)
Iowa (3)
Japan (279)
Kansas (11)
Kentucky (4)
Louisiana (7)
Maine (7)
Maryland (319)
Massachusetts (2244)
Michigan (78)
Minnesota (57)
Missouri (7)
Montana (2)
Nebraska (6)
Nevada (20)
New Hampshire (4)
New Jersey (638)
New Mexico (4)
New York (669)
North Carolina (320)
North Dakota (5)
Northern California (1202)
Ohio (60)
Oklahoma (1)
Oregon (6)
Pennsylvania (500)
Puerto Rico (3)
Rhode Island (8)
South America (229)
South Carolina (3)
Southern California (881)
Tennessee (7)
Texas (300)
United States (8615)
Utah (162)
Virginia (87)
Washington D.C. (14)
Washington State (208)
Wisconsin (21)
153,107 Results for "oxford genetics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oxford-Harrington Rare Disease Centre Invites Proposals for 2026 Award
January 16, 2026
·
2 min read
Press Releases
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
January 12, 2026
·
2 min read
Press Releases
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
November 21, 2025
·
4 min read
Press Releases
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
January 6, 2026
·
6 min read
Press Releases
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
November 12, 2025
·
2 min read
Press Releases
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet’s Disease Published in Rheumatology (Oxford)
December 19, 2025
·
14 min read
Press Releases
Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
December 10, 2025
·
4 min read
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Oxford Set To Benefit From New Technology to Diagnose Disease
October 8, 2025
·
3 min read
Press Releases
Perspectum and InHealth Announce National Diagnostics Partnership to Boost Oxford CDC Capacity and Widen Access to Advanced MRI Across the UK
December 2, 2025
·
3 min read
1 of 15,311
Next
